Search Results 341-350 of 14916 for alt

1. A Study to Evaluate the Effectiveness of Acetazolamide to Treat Patients with Ataxia in PMM2-Congenital Disorder of Glycosylation - Mayo Clinic

   Participation eligibility · Hepatic impairment defined as AST/ALT > 5 x ULN in the last 12 months. · Renal impairment defined as serum creatinine 1.5-1.9 x ULN ...

2. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

   Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 2.5 × ULN; AST and ALT ≤ 5 × ULN if liver metastases are present.. Serum creatinine ...

3. Auranofin and Sirolimus in Treating Participants With Ovarian Cancer - Mayo Clinic

   ... [ALT]) =< 3 x ULN or SGOT (AST) and SGPT (ALT) =< 5 x ULN is acceptable if liver has tumor involvement; Obtained =< 14 days prior to registration: Creatinine ...

4. Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia - Mayo Clinic

   AMKL PATIENTS: Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 2.5 x ULN. AMKL PATIENTS: Creatinine < 1.5 x ULN or calculated creatinine ...

5. A Study of to Evaluate Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer - Mayo Clinic

   AST(SGOT)/ALT(SGPT) ≤ 2.5 x IULN. Creatinine ≤ IULN OR creatinine clearance ≥ 60 mL/min/1.73 m^2 for patients with creatinine levels above institutional ...

6. Actinium Therapy For Late-stage Aggressive Sarcomas - Mayo Clinic

   Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 2.5 × ULN. 6. Calculated creatinine clearance ≥ 60 mL/min. 6. Coagulation parameters ...

7. A Study of Tamoxifen Citrate for Treating Patients with Metastatic or Recurrent Breast Cancer - Mayo Clinic

   Menopausal status not specified; Total bilirubin ≤ 1.5 times upper limit of normal (ULN); ALT and AST ≤ 2.5 times ULN (≤ 5 times ULN if liver metastases ...

8. A Study to Evaluate the Safety and Effectiveness of the Drug TTP399 to Target A1c in Type 2 Diabetics - Mayo Clinic

   Clinically significant abnormal lab values including eGFR <50ml/min/1.73m2, ALT, bilirubin or AST >1.5 X ULN, hypokalemia or other clinically significant ...

9. Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

   Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< 110 units per liter (U/L); for the purpose of this study, the ULN for SGPT is ...

10. Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer - Mayo Clinic

    Note: If alanine aminotransferase (ALT) is performed instead of AST (per institution's standard practice), the ALT value must be less than or equal to 1.5 x ...